Clinical Trial Update: Proteomic Signature in Breast Cancer: Correlation With Tumor Response to Neo-adjuvant Chemotherapy [NA]

View source ↗

Summary

A completed study evaluating a proteomic signature in breast cancer and its relationship to tumor response after neoadjuvant chemotherapy.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: Centre Oscar Lambret | Conditions: Breast Cancer | NA | Status: COMPLETED